You should not take a GLP-1 medication if you have: A history of pancreatitis A type of thyroid cancer called medullary thyroid cancer A condition called multiple endocrine neoplasia Severe diabetic eye disease (diabetic retinopathy) You also should not take GLP-1 medications if you are pregnant
The Premier Difference This isnt just a prescription handed over a counter, this is support when and where you need it most
Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
Unreconstituted powder is more stable but should still be kept cool and away from light
Breaking a plateau It is completely normal for weight loss to stall as your body gets used to being lighter
Ideal Candidates Patients for whom diet and exercise alone have not effectively helped them lose weight may be good candidates for GLP-1